Aina Yuan

584 total citations
25 papers, 449 citations indexed

About

Aina Yuan is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Aina Yuan has authored 25 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Aina Yuan's work include Radiopharmaceutical Chemistry and Applications (18 papers), Medical Imaging Techniques and Applications (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Aina Yuan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (18 papers), Medical Imaging Techniques and Applications (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Aina Yuan collaborates with scholars based in United States, India and Germany. Aina Yuan's co-authors include Gerald L. DeNardo, Sally J. DeNardo, Sui Shen, Robert T. OʼDonnell, Kathleen R. Lamborn, Diane A. DeNardo, David L. Kukis, Gary R. Mirick, D. Goldstein and Carol M. Richman and has published in prestigious journals such as Cancer, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Aina Yuan

25 papers receiving 437 citations

Peers

Countries citing papers authored by Aina Yuan

Since Specialization

Citations

This map shows the geographic impact of Aina Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aina Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aina Yuan more than expected).

Fields of papers citing papers by Aina Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aina Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aina Yuan. The network helps show where Aina Yuan may publish in the future.

Co-authorship network of co-authors of Aina Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Aina Yuan. A scholar is included among the top collaborators of Aina Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aina Yuan. Aina Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma 2007 ·International Journal of Oncology ·Gerald L. DeNardo, Saphon Hok, Arutselvan Natarajan, Monique Cosman, Sally J. DeNardo, Felice C. Lightstone, Gary R. Mirick, Aina Yuan, Julie Perkins, (unknown), Jöerg Lehmann, (unknown)	10
2	Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Jöerg Lehmann, Gerald L. DeNardo, Aina Yuan, Sui Shen, Robert T. OʼDonnell, Carol M. Richman, Sally J. DeNardo	2
3	Splenic Volume Change and Nodal Tumor Response in Non-Hodgkin's Lymphoma Patients after Radioimmunotherapy Using Radiolabeled Lym-1 Antibody 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·Sui Shen, Gerald L. DeNardo, Aina Yuan, (unknown), Robert T. OʼDonnell, Sally J. DeNardo	7
4	Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer 2005 ·Clinical Cancer Research ·Sally J. DeNardo, Carol M. Richman, Huguette Albrecht, Peter Burke, (unknown), Aina Yuan, Jeff Gregg, Robert T. OʼDonnell, Gerald L. DeNardo	22
5	Does Paclitaxel (Taxol) Given after 111In-Labeled Monoclonal Antibodies Increase Tumor-Cumulated Activity in Epithelial Cancers? 2005 ·Clinical Cancer Research ·Laird Miers, Kathleen R. Lamborn, Aina Yuan, Carol M. Richman, Arutselvan Natarajan, Sally J. DeNardo, Gerald L. DeNardo	10
6	Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry. 2005 ·PubMed ·Sui Shen, Sally J. DeNardo, Carol M. Richman, Aina Yuan, (unknown), Robert T. OʼDonnell, Linda A. Kroger, Gerald L. DeNardo	6
7	Impact of Interpatient Pharmacokinetic Variability on Design Considerations for Therapy with Radiolabeled MAbs 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·Gerald L. DeNardo, Aina Yuan, D. Goldstein, Carol M. Richman, Robert T. OʼDonnell, Sui Shen, (unknown), Sally J. DeNardo	6
8	Application of MINERVA Monte Carlo Simulations to Targeted Radionuclide Therapy 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Christine L. Hartmann Siantar, L Dauffy, David W. Nigg, C.A. Wemple, Aina Yuan, Gerald L. DeNardo	16
9	¹³¹ I-Lym-1 in Mice Implanted with Human Burkitt's Lymphoma (Raji) Tumors: Loss of Tumor Specificity due to Radiolysis 2000 ·Cancer Biotherapy and Radiopharmaceuticals ·Gerald L. DeNardo, Sally J. DeNardo, Barry W. Wessels, David L. Kukis, (unknown), Aina Yuan	10
10	Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. 2000 ·PubMed ·Gerald L. DeNardo, Robert T. OʼDonnell, Sui Shen, Linda A. Kroger, Aina Yuan, Claude F. Meares, David L. Kukis, Sally J. DeNardo	25
11	Radioimmunotherapy of Acquired Immunodeficiency Syndrome (AIDS) Associated Lymphoma 1999 ·Cancer Biotherapy and Radiopharmaceuticals ·Robert T. OʼDonnell, Bryan R. Leigh, Scott Christensen, D S Goldstein, David L. Kukis, Sui Shen, Aina Yuan, Diane A. DeNardo, Linda A. Kroger, Gerald L. DeNardo	3
12	A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma. 1999 ·PubMed ·Robert T. OʼDonnell, Gerald L. DeNardo, David L. Kukis, Kathleen R. Lamborn, Sui Shen, Aina Yuan, D. Goldstein, Catherine E. Carr, Gary R. Mirick, Sally J. DeNardo	61
13	Quantification of iodine-131 in tumors using a threshold based on image contrast 1998 ·European Journal of Nuclear Medicine and Molecular Imaging ·Gerald L. DeNardo, Sui Shen, Sally J. DeNardo, (unknown), Kathleen R. Lamborn, Diane A. DeNardo, Aina Yuan	12
14	Imaging for improved prediction of myelotoxicity after radioimmunotherapy 1997 ·Cancer ·Diane A. DeNardo, Gerald L. DeNardo, Robert T. OʼDonnell, (unknown), Sui Shen, Aina Yuan, Sally J. DeNardo	2
15	Reproducibility of operator processing for radiation dosimetry 1997 ·Nuclear Medicine and Biology ·Sui Shen, Gerald L. DeNardo, Sally J. DeNardo, Aina Yuan, Diane A. DeNardo, Kathleen R. Lamborn	16
16	Practical determination of organ S values for individual patients for therapy 1997 ·Nuclear Medicine and Biology ·Sui Shen, Gerald L. DeNardo, Daniel J. Macey, Robert T. OʼDonnell, Aina Yuan, Diane A. DeNardo, Sally J. DeNardo	5
17	Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources. 1997 ·PubMed ·Sang Moo Lim, Gerald L. DeNardo, Diane A. DeNardo, Sui Shen, Aina Yuan, Robert T. OʼDonnell, Sally J. DeNardo	33
18	Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies 1997 ·Cancer ·Sui Shen, Gerald L. DeNardo, Robert T. OʼDonnell, Aina Yuan, Diane A. DeNardo, Sally J. DeNardo	14
19	The biologic window for chimeric l6 radioimmunotherapy 1994 ·Cancer ·Sally J. DeNardo, Gary R. Mirick, Linda A. Kroger, L.F. O'Grady, Kent L. Erickson, Aina Yuan, Kathleen R. Lamborn, Ingegerd Hellström, Karl Erik Hellström, Gerald L. DeNardo	42
20	Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion 1992 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Zhao–You Tang, Kang–Da Liu, Dong Zhou, Ji‐Zhen Lu, Aina Yuan, (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact